Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00737347 · ClinicalTrials.gov registry record · Phase 3
Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
A Phase 3 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 3
- Development phase
- 39
- Enrollment target
NCT00737347 is a Phase 3 study that has completed, run by Northwestern University. The registered enrollment target is 39 participants.
The verdict
NCT00737347, a Phase 3 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.
Interventions
- BEHAVIORAL Lifestyle modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00737347
The ClinicalTrials.gov registry entry for NCT00737347 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lifestyle modification is the first listed.
NCT00737347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00737347 about?
NCT00737347 is a clinical study titled "Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone". The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.
What is the current status of trial NCT00737347?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 39 participants. The study started on 2003-09. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00737347?
The interventions under investigation include: Lifestyle modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT00737347?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.